The results indicated that FR-gE with XUA01 generated high amounts of IFN-γ and IL-2, comparable to those induced by Shingrix and significantly higher than the other two live attenuated vaccines, suggesting that FR-gE holds potential as an immunogen candidate for a herpes zoster vaccine. Here, IL2 is linked to herpes zoster.